CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C05304 | BRD-K09231502 | BRD-K09231502 | -- | -- | -- | Details |
| C05305 | BRD-K09232527 | BRD-K09232527 | -- | -- | -- | Details |
| C05306 | BRD-K09244864 | BRD-K09244864 | -- | -- | -- | Details |
| C05307 | BRD-K09248459 | BRD-K09248459 | -- | -- | -- | Details |
| C05308 | BRD-K09250623 | BRD-K09250623 | -- | -- | -- | Details |
| C05309 | BRD-K09250647 | BRD-K09250647 | -- | -- | -- | Details |
| C05310 | BRD-K09253654 | BRD-K09253654 | -- | -- | -- | Details |
| C05311 | BRD-K09255212 | clioquinol | -- | -- | -- | Details |
| C05312 | BRD-K09258973 | BRD-K09258973 | -- | -- | -- | Details |
| C05313 | BRD-K09260588 | BRD-K09260588 | -- | -- | -- | Details |
| C05314 | BRD-K09261031 | BRD-K09261031 | -- | -- | -- | Details |
| C05315 | BRD-K09261379 | BRD-K09261379 | -- | -- | -- | Details |
| C05316 | BRD-K09271653 | BRD-K09271653 | -- | -- | -- | Details |
| C05317 | BRD-K09275191 | BRD-K09275191 | -- | -- | -- | Details |
| C05318 | BRD-K09276254 | BRD-K09276254 | -- | -- | -- | Details |
| C05319 | BRD-K09290524 | BRD-K09290524 | -- | -- | -- | Details |
| C05320 | BRD-K09292709 | BRD-K09292709 | -- | -- | -- | Details |
| C05321 | BRD-K09295309 | BRD-K09295309 | -- | -- | -- | Details |
| C05322 | BRD-K09295900 | BRD-K09295900 | -- | -- | -- | Details |
| C05323 | BRD-K09299610 | BRD-K09299610 | -- | -- | -- | Details |
| C05324 | BRD-K09300252 | BRD-K09300252 | -- | -- | -- | Details |
| C05325 | BRD-K09301754 | BRD-K09301754 | -- | -- | -- | Details |
| C05326 | BRD-K09303054 | BRD-K09303054 | -- | -- | -- | Details |
| C05327 | BRD-K09304381 | BRD-K09304381 | -- | -- | -- | Details |
| C05328 | BRD-K09308989 | BRD-K09308989 | -- | -- | -- | Details |
| C05329 | BRD-K09324015 | BRD-K09324015 | -- | -- | -- | Details |
| C05330 | BRD-K09324395 | BRD-K09324395 | -- | -- | -- | Details |
| C05331 | BRD-K09325707 | BRD-K09325707 | -- | -- | -- | Details |
| C05332 | BRD-K09327126 | BRD-K09327126 | -- | -- | -- | Details |
| C05333 | BRD-K09328667 | BRD-K09328667 | -- | -- | -- | Details |
| C05334 | BRD-K09329774 | BRD-K09329774 | -- | -- | -- | Details |
| C05335 | BRD-K09333299 | BRD-K09333299 | -- | -- | -- | Details |
| C05336 | BRD-K09335206 | BRD-K09335206 | -- | -- | -- | Details |
| C05337 | BRD-K09337184 | BRD-K09337184 | -- | -- | -- | Details |
| C05338 | BRD-K09353376 | tariquidar | ABCB1 | P-glycoprotein inhibitor | -- | Details |
| C05339 | BRD-K09366011 | BRD-K09366011 | -- | -- | 1-(2,3-dihydro-1H-indol-1-yl)-2-(phenylsulfanyl)-1-ethanone | Details |
| C05340 | BRD-K09366813 | BRD-K09366813 | -- | -- | -- | Details |
| C05341 | BRD-K09367542 | BRD-K09367542 | -- | -- | -- | Details |
| C05342 | BRD-K09372874 | merimepodib | IMPDH1 | IMPDH inhibitor | -- | Details |
| C05343 | BRD-K09373762 | BRD-K09373762 | -- | -- | -- | Details |
| C05344 | BRD-K09376136 | BRD-K09376136 | -- | -- | -- | Details |
| C05345 | BRD-K09376533 | BRD-K09376533 | -- | -- | -- | Details |
| C05346 | BRD-K09376957 | BRD-K09376957 | -- | -- | -- | Details |
| C05347 | BRD-K09378334 | BRD-K09378334 | -- | -- | -- | Details |
| C05348 | BRD-K09388341 | BRD-K09388341 | -- | -- | -- | Details |
| C05349 | BRD-K09388706 | BRD-K09388706 | -- | -- | -- | Details |
| C05350 | BRD-K09395335 | BRD-K09395335 | -- | -- | -- | Details |
| C05351 | BRD-K09397065 | SR-57227A | HTR3A | Serotonin receptor agonist | -- | Details |
| C05352 | BRD-K09397553 | BRD-K09397553 | -- | -- | -- | Details |
| C05353 | BRD-K09398529 | BRD-K09398529 | -- | -- | -- | Details |
| C05354 | BRD-K09404347 | BRD-K09404347 | -- | -- | -- | Details |
| C05355 | BRD-K09404826 | BRD-K09404826 | -- | -- | -- | Details |
| C05356 | BRD-K09405682 | BRD-K09405682 | -- | -- | -- | Details |
| C05357 | BRD-K09407750 | BRD-K09407750 | -- | -- | -- | Details |
| C05358 | BRD-K09411281 | BRD-K09411281 | -- | -- | -- | Details |
| C05359 | BRD-K09414286 | BRD-K09414286 | -- | -- | -- | Details |
| C05360 | BRD-K09416407 | BRD-K09416407 | -- | -- | -- | Details |
| C05361 | BRD-K09416995 | lovastatin | HMGCR | HMGCR inhibitor | -- | Details |
| C05362 | BRD-K09423613 | SA-441181 | -- | -- | -- | Details |
| C05363 | BRD-K09424864 | BRD-K09424864 | -- | -- | -- | Details |
| C05364 | BRD-K09426613 | BRD-K09426613 | -- | -- | -- | Details |
| C05365 | BRD-K09426783 | TAS-103 | TOP1 | Topoisomerase inhibitor | -- | Details |
| C05366 | BRD-K09428486 | BRD-K09428486 | -- | -- | -- | Details |
| C05367 | BRD-K09430433 | BRD-K09430433 | -- | -- | -- | Details |
| C05368 | BRD-K09432998 | BRD-K09432998 | -- | -- | -- | Details |
| C05369 | BRD-K09434518 | BRD-K09434518 | -- | -- | -- | Details |
| C05370 | BRD-K09436313 | prostaglandin | PTGDR2 | Prostanoid receptor antagonist | -- | Details |
| C05371 | BRD-K09444102 | BRD-K09444102 | -- | -- | -- | Details |
| C05372 | BRD-K09450441 | BRD-K09450441 | -- | -- | -- | Details |
| C05373 | BRD-K09453969 | BRD-K09453969 | -- | -- | -- | Details |
| C05374 | BRD-K09454191 | BRD-K09454191 | -- | -- | -- | Details |
| C05375 | BRD-K09454555 | BRD-K09454555 | -- | -- | -- | Details |
| C05376 | BRD-K09458434 | BRD-K09458434 | -- | -- | -- | Details |
| C05377 | BRD-K09459434 | BRD-K09459434 | -- | -- | -- | Details |
| C05378 | BRD-K09460252 | BRD-K09460252 | -- | -- | -- | Details |
| C05379 | BRD-K09460582 | BRD-K09460582 | -- | -- | -- | Details |
| C05380 | BRD-K09468701 | BRD-K09468701 | -- | -- | -- | Details |
| C05381 | BRD-K09471561 | levofloxacin | -- | -- | -- | Details |
| C05382 | BRD-K09473191 | BRD-K09473191 | -- | -- | -- | Details |
| C05383 | BRD-K09485525 | GANT-61 | GLI1; GLI2 | GLI antagonist | -- | Details |
| C05384 | BRD-K09487323 | BRD-K09487323 | -- | -- | -- | Details |
| C05385 | BRD-K09487932 | BRD-K09487932 | -- | -- | -- | Details |
| C05386 | BRD-K09497549 | kawain | MTOR | MTOR inhibitor; Sodium channel blocker; Calcium channel modulator | -- | Details |
| C05387 | BRD-K09499853 | KU-0060648 | PIK3CA; PIK3CB; PIK3CD; PRKDC | PI3K inhibitor; DNA dependent protein kinase inhibitor | -- | Details |
| C05388 | BRD-K09503339 | BRD-K09503339 | -- | -- | -- | Details |
| C05389 | BRD-K09511124 | BRD-K09511124 | -- | -- | -- | Details |
| C05390 | BRD-K09517037 | BRD-K09517037 | -- | -- | -- | Details |
| C05391 | BRD-K09521750 | BRD-K09521750 | -- | -- | -- | Details |
| C05392 | BRD-K09521953 | BRD-K09521953 | -- | -- | -- | Details |
| C05393 | BRD-K09523238 | BRD-K09523238 | -- | -- | -- | Details |
| C05394 | BRD-K09526594 | BRD-K09526594 | -- | -- | -- | Details |
| C05395 | BRD-K09527783 | BRD-K09527783 | -- | -- | -- | Details |
| C05396 | BRD-K09528868 | BRD-K09528868 | -- | -- | -- | Details |
| C05397 | BRD-K09537769 | NU-7026 | PRKDC | MTOR inhibitor; PI3K inhibitor; DNA dependent protein kinase inhibitor | -- | Details |
| C05398 | BRD-K09540583 | BRD-K09540583 | -- | -- | -- | Details |
| C05399 | BRD-K09541527 | BRD-K09541527 | -- | -- | -- | Details |
| C05400 | BRD-K09542523 | BRD-K09542523 | -- | -- | -- | Details |
| C05401 | BRD-K09547783 | BRD-K09547783 | -- | -- | -- | Details |
| C05402 | BRD-K09549677 | mibefradil | CACNA1C; CACNA1I; CACNA1H; CACNA1G | T-type calcium channel blocker | -- | Details |
| C05403 | BRD-K09551497 | BRD-K09551497 | -- | -- | -- | Details |